QJM

Associations Between Glucagon-like Peptide-1 Receptor Agonists and Respiratory Outcomes in Chronic Obstructive pulmonary disease and Diabetes

By Kuang-Ming Liao, Ya-Wen Tsai, Konstantinos Kostikas, Chih-Cheng Lai

Cohort study in peopleInterventions

The paper

Kuang-Ming Liao, Ya-Wen Tsai, Konstantinos Kostikas, Chih-Cheng Lai

Min-Hwei College of Health Care Management; National Sun Yat-sen University

QJM, 17 Aug 2026

doi.org/10.1093/qjmed/hcag217 PubMed 42606949

Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes